Table of Contents
Editorial
Mike Kew: A physician-scientist, teacher and role model extraordinaire with an enduring influence on excellence and mentorship in medicine | |
N Ntusi | 2-3 |
Introduction
Introduction | |
J E J Krige | 3 |
Michael Charles Kew: A chronicle of his career | |
J H Hoofnagle | 4-5 |
Professor Mike Kew and the Royal Free Hospital | |
M Pinzani | 6 |
Tributes
Tributes from senior academics from the University of the Witwatersrand | |
T H Bothwell | 7-9 |
Tributes from the Gastroenterology Foundation of South Africa | |
C Kassianides | 10-12 |
Research
Towards the elimination of hepatitis B and hepatocellular carcinoma | |
C W Spearman | 13-16 |
Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus | |
A Kramvis | 17-21 |
Current and future directions for the management of hepatitis B | |
G Dusheiko | 22-30 |
The global elimination of hepatitis C? | |
M W Sonderup | 31-34 |
Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance – implications for sub-Saharan Africa | |
K Zakharia, C A Luther, H Alsabbak, L R Roberts | 35-40 |
Molecular and cellular oncogenic mechanisms in hepatocellular carcinoma | |
M Setshedi, M Andersson, M M Kgatle, L Roberts | 41-46 |
Prevention of hepatocellular carcinoma with antiviral therapy | |
AM Di Bisceglie | 47-50 |
Hepatocellular carcinoma in sub-Saharan Africa – the way forward | |
E Jonas | 51 |